DE60222662D1 - Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung - Google Patents

Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung

Info

Publication number
DE60222662D1
DE60222662D1 DE60222662T DE60222662T DE60222662D1 DE 60222662 D1 DE60222662 D1 DE 60222662D1 DE 60222662 T DE60222662 T DE 60222662T DE 60222662 T DE60222662 T DE 60222662T DE 60222662 D1 DE60222662 D1 DE 60222662D1
Authority
DE
Germany
Prior art keywords
preventive
azetylcarnitine
medicament
post
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222662T
Other languages
English (en)
Other versions
DE60222662T2 (de
Inventor
Menotti Calvani
Luigi Mosconi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE60222662D1 publication Critical patent/DE60222662D1/de
Publication of DE60222662T2 publication Critical patent/DE60222662T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE60222662T 2001-05-29 2002-05-24 Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung Expired - Lifetime DE60222662T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM20010293 2001-05-29
IT2001RM000293A ITRM20010293A1 (it) 2001-05-29 2001-05-29 Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
PCT/IT2002/000336 WO2002096409A1 (en) 2001-05-29 2002-05-24 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain

Publications (2)

Publication Number Publication Date
DE60222662D1 true DE60222662D1 (de) 2007-11-08
DE60222662T2 DE60222662T2 (de) 2008-06-26

Family

ID=11455557

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222662T Expired - Lifetime DE60222662T2 (de) 2001-05-29 2002-05-24 Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung

Country Status (18)

Country Link
US (2) US20040152781A1 (de)
EP (1) EP1399141B1 (de)
JP (1) JP4287660B2 (de)
KR (1) KR100873748B1 (de)
AT (1) ATE374021T1 (de)
CA (1) CA2448242C (de)
CY (1) CY1107037T1 (de)
CZ (1) CZ20033220A3 (de)
DE (1) DE60222662T2 (de)
DK (1) DK1399141T3 (de)
ES (1) ES2290292T3 (de)
HU (1) HUP0401294A3 (de)
IT (1) ITRM20010293A1 (de)
MX (1) MXPA03010919A (de)
PL (1) PL367616A1 (de)
PT (1) PT1399141E (de)
SK (1) SK287559B6 (de)
WO (1) WO2002096409A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040606A1 (it) * 2004-12-13 2005-03-13 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica.
JP5685362B2 (ja) * 2005-04-26 2015-03-18 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150688B1 (de) * 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salze von L-Carnitin und Alkanoyl-L-Carnitinen sowie Verfahren zur Herstellung derselben
IT1196564B (it) * 1986-08-04 1988-11-16 Sigma Tau Ind Farmaceuti Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.

Also Published As

Publication number Publication date
EP1399141A1 (de) 2004-03-24
ITRM20010293A0 (it) 2001-05-29
DE60222662T2 (de) 2008-06-26
SK287559B6 (sk) 2011-02-04
ATE374021T1 (de) 2007-10-15
KR100873748B1 (ko) 2008-12-12
HUP0401294A3 (en) 2008-04-28
HUP0401294A2 (hu) 2004-12-28
PT1399141E (pt) 2007-11-16
JP2004532865A (ja) 2004-10-28
JP4287660B2 (ja) 2009-07-01
CA2448242A1 (en) 2002-12-05
ES2290292T3 (es) 2008-02-16
EP1399141B1 (de) 2007-09-26
KR20040003030A (ko) 2004-01-07
ITRM20010293A1 (it) 2002-11-29
DK1399141T3 (da) 2008-01-02
CA2448242C (en) 2011-01-11
WO2002096409A1 (en) 2002-12-05
US20040152781A1 (en) 2004-08-05
PL367616A1 (en) 2005-03-07
CZ20033220A3 (en) 2004-06-16
US20090062388A1 (en) 2009-03-05
MXPA03010919A (es) 2004-02-27
SK15842003A3 (sk) 2004-06-08
CY1107037T1 (el) 2012-09-26

Similar Documents

Publication Publication Date Title
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
MY127290A (en) New use of flibanserin
EP1933833B8 (de) Therapie zur behandlung der überaktiven blase
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
HK1068606A1 (en) Novel aminobenzoephenones
IL170519A (en) Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
UA89753C2 (ru) Применение модафинила и антидепрессанта при лечении депрессии и для сокращения времени до начала действия антидепрессанта
DE60222662D1 (de) Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος
DE60215219D1 (de) Verwendung von darifenacin zur behandlung des harndrangs
ATE345124T1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
DE60206391D1 (de) Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen
DE602004025001D1 (de) Verbindungen zur behandlung von neuropathischen schmerzen und migräne
ATE442848T1 (de) Isoxazolsäure-derivat zur linderung neuropathischer schmerzen

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: CALVANI, MENOTTI, POMEZIA, IT

Inventor name: MOSCONI, LUIGI, POMEZIA, IT

8364 No opposition during term of opposition